SLNOSoleno Therapeutics Inc
SLNO
Soleno Therapeutics Inc8,239
Mkt Cap
$1.72BVolume
921,852.0052W High
$90.3252W Low
$32.63PE Ratio
149.80SLNO Fundamentals
Price
$33.62Prev Close
$33.39Open
$33.2450D MA
$40.75Beta
0.85Avg. Volume
1.49MEPS (Annual)
$0.3909P/B
3.88Rev/Employee
$1.05M$2,172.50
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Conducting Sham Clinical Trials: Levi & Korsinsky
Levi & Korsinsky, LLP reminds purchasers of Soleno Therapeutics, Inc. (NASDAQ: SLNO) securities of a pending securities class action. THE CASE: A class action seeks to recover damages for investors...
Business Wire·12h ago
SLNO Shareholder Alert: Soleno Therapeutics, Inc. Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm
SLNO Shareholder Alert: Soleno Therapeutics, Inc. Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm SLNO Shareholder Alert: Soleno Therapeutics, Inc. Securities...
PR Newswire·19h ago
Holocene Advisors LP Trims Stake in Soleno Therapeutics, Inc. $SLNO
Holocene Advisors LP lessened its holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 13.5% during the 3rd quarter, according to the company in its most recent 13F filing with the...
MarketBeat·22h ago
Deadline Alert: Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 5, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise...
Business Wire·1d ago
SLNO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026
SLNO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026 SLNO INVESTOR DEADLINE APPROACHING: Faruqi...
PR Newswire·2d ago
Soleno Therapeutics Target of Unusually Large Options Trading (NASDAQ:SLNO)
Soleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) saw some unusual options trading activity on Monday. Stock traders acquired 5,314 put options on the company. This represents an increase of...
MarketBeat·2d ago
301,000 Shares in Soleno Therapeutics, Inc. $SLNO Purchased by Kingdon Capital Management L.L.C.
Kingdon Capital Management L.L.C. purchased a new stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the...
MarketBeat·2d ago
Granahan Investment Management LLC Has $7.39 Million Holdings in Soleno Therapeutics, Inc. $SLNO
Granahan Investment Management LLC grew its stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 82.2% in the third quarter, according to the company in its most recent Form 13F filing...
MarketBeat·2d ago
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Given Average Rating of "Moderate Buy" by Brokerages
Soleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) has been given an average recommendation of "Moderate Buy" by the fifteen brokerages that are currently covering the firm, MarketBeat.com...
MarketBeat·2d ago
Commodore Capital LP Raises Stock Position in Soleno Therapeutics, Inc. $SLNO
Commodore Capital LP raised its holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 121.3% in the third quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·3d ago
<
1
2
...
>